Erdheim-Chester disease: consensus recommendations for evaluation, diagnosis, and treatment in the molecular era von Goyal, Gaurav, Heaney, Mark L., Collin, Matthew, Cohen-Aubart, Fleur, Vaglio, Augusto, Durham, Benjamin H., Hershkovitz-Rokah, Oshrat, Girschikofsky, Michael, Jacobsen, Eric D., Toyama, Kazuhiro, Goodman, Aaron M., Hendrie, Paul, Cao, Xin-xin, Estrada-Veras, Juvianee I., Shpilberg, Ofer, Abdo, André, Kurokawa, Mineo, Dagna, Lorenzo, McClain, Kenneth L., Mazor, Roei D., Picarsic, Jennifer, Janku, Filip, Go, Ronald S., Haroche, Julien, Diamond, Eli L.

Volltext

The response to lymphodepletion impacts PFS in patients with aggressive non-Hodgkin lymphoma treated with CD19 CAR T cells von Hirayama, Alexandre V., Gauthier, Jordan, Hay, Kevin A., Voutsinas, Jenna M., Wu, Qian, Gooley, Ted, Li, Daniel, Cherian, Sindhu, Chen, Xueyan, Pender, Barbara S., Hawkins, Reed M., Vakil, Aesha, Steinmetz, Rachel N., Acharya, Utkarsh H., Cassaday, Ryan D., Chapuis, Aude G., Dhawale, Tejaswini M., Hendrie, Paul C., Kiem, Hans-Peter, Lynch, Ryan C., Ramos, Jorge, Shadman, Mazyar, Till, Brian G., Riddell, Stanley R., Maloney, David G., Turtle, Cameron J.

Volltext

Aleukemic mast cell leukemia, well-differentiated and chronic type von Chen, Kenneth, Hendrie, Paul C., Naresh, Kikkeri N.

Volltext

Survival of patients with newly diagnosed high-grade myeloid neoplasms who do not meet standard trial eligibility von Percival, Mary-Elizabeth M, Othus, Megan, Mirahsani, Sarah, Gardner, Kelda M, Shaw, Carole, Halpern, Anna B, Becker, Pamela S, Hendrie, Paul C, Sorror, Mohamed L, Walter, Roland B, Estey, Elihu H

Volltext

Gemtuzumab ozogamicin in combination with vorinostat and azacitidine in older patients with relapsed or refractory acute myeloid leukemia: a phase I/II study von Walter, Roland B, Medeiros, Bruno C, Gardner, Kelda M, Orlowski, Kaysey F, Gallegos, Leonel, Scott, Bart L, Hendrie, Paul C, Estey, Elihu H

Volltext

Phase 1/2 trial of GCLAM with dose-escalated mitoxantrone for newly diagnosed AML or other high-grade myeloid neoplasms von Halpern, Anna B., Othus, Megan, Huebner, Emily M., Scott, Bart L., Becker, Pamela S., Percival, Mary-Elizabeth M., Hendrie, Paul C., Gardner, Kelda M., Chen, Tara L., Buckley, Sarah A., Orlowski, Kaysey F., Anwar, Asma, Appelbaum, Frederick R., Erba, Harry P., Estey, Elihu H., Walter, Roland B.

Volltext

Phase I/II trial of cladribine, high-dose cytarabine, mitoxantrone, and G-CSF with dose-escalated mitoxantrone for relapsed/refractory acute myeloid leukemia and other high-grade m... von Halpern, Anna B, Othus, Megan, Huebner, Emily M, Scott, Bart L, Hendrie, Paul C, Percival, Mary-Elizabeth M, Becker, Pamela S, Smith, Heather A, Oehler, Vivian G, Orozco, Johnnie J, Cassaday, Ryan D, Gardner, Kelda M, Chen, Tara L, Buckley, Sarah A, Orlowski, Kaysey F, Anwar, Asma, Estey, Elihu H, Walter, Roland B

Volltext

A novel GAB2::BRAF fusion in cutaneous non‐Langerhans‐cell histiocytosis with systemic involvement von Wu, Bicong, Konnick, Eric Q., Kimble, Erik L., Hendrie, Paul C., Shinohara, Michi M., Moshiri, Ata S.

Volltext

Outcomes based on treatment setting in refractory acute myeloid leukemia and other high-grade myeloid malignancies von Kopmar, Noam E., Othus, Megan, Gardner, Kelda M., Shaw, Carole, Halpern, Anna B., Scott, Bart L., Hendrie, Paul C., Walter, Roland B., Becker, Pamela S., Estey, Elihu H., Percival, Mary-Elizabeth M.

Volltext

Unsatisfactory efficacy in randomized study of reduced-dose CPX-351 for medically less fit adults with newly diagnosed acute myeloid leukemia or other high-grade myeloid neoplasm von Walter, Roland B, Othus, Megan, Orlowski, Kaysey F, McDaniel, Emily N, Scott, Bart L, Becker, Pamela S, Percival, Mary-Elizabeth M, Hendrie, Paul C, Medeiros, Bruno C, Chiarella, Michael T, Louie, Arthur C, Estey, Elihu H

Volltext

Erdheim–Chester disease von Starkebaum, Gordon, Hendrie, Paul

Volltext

Phase 1/2 Trial of CLAG-M with Dose-Escalated Mitoxantrone in Combination with Fractionated-Dose Gemtuzumab Ozogamicin for Newly Diagnosed Acute Myeloid Leukemia and Other High-Gra... von Godwin, Colin, Rodríguez-Arbolí, Eduardo, Othus, Megan, Halpern, Anna, Appelbaum, Jacob, Percival, Mary-Elizabeth, Hendrie, Paul, Oehler, Vivian, Keel, Siobán, Abkowitz, Janis, Cooper, Jason, Cassaday, Ryan, Estey, Elihu, Walter, Roland

Volltext

Hyper‐CVAD versus dose‐adjusted EPOCH as initial treatment for adults with acute lymphoblastic leukemia von Zarling, Lucas C., Stevenson, Philip A., Soma, Lorinda A., Martino, Christen H., Percival, Mary‐Elizabeth M., Halpern, Anna B., Ghiuzeli, Cristina M., Becker, Pamela S., Oehler, Vivian G., Cooper, Jason P., Orozco, Johnnie J., Hendrie, Paul C., Walter, Roland B., Estey, Elihu H., Cassaday, Ryan D.

Volltext

Clofarabine with high dose cytarabine and granulocyte colony‐stimulating factor (G‐CSF) priming for relapsed and refractory acute myeloid leukaemia von Becker, Pamela S., Kantarjian, Hagop M., Appelbaum, Frederick R., Petersdorf, Stephen H., Storer, Barry, Pierce, Sherry, Shan, Jianqin, Hendrie, Paul C., Pagel, John M., Shustov, Andrei R., Stirewalt, Derek L., Faderl, Stephan, Harrington, Elizabeth, Estey, Elihu H.

Volltext

Gene targeting with viral vectors von Hendrie, Paul C, Russell, David W

Volltext

Early hospital discharge after intensive induction chemotherapy for adults with acute myeloid leukemia or other high-grade myeloid neoplasm von Halpern, Anna B., Howard, Nicholas P., Othus, Megan, Hendrie, Paul C., Baclig, Nikita V., Buckley, Sarah A., Percival, Mary-Elizabeth M., Becker, Pamela S., Scott, Bart L., Oehler, Vivian G., Gernsheimer, Terry B., Keel, Siobán B., Orozco, Johnnie J., Cassaday, Ryan D., Shustov, Andrei R., Hartley, Garrett A., Welch, Verna L., Estey, Elihu H., Walter, Roland B.

Volltext

Phase 1/2 study of sorafenib added to cladribine, high-dose cytarabine, G-CSF, and mitoxantrone in untreated AML von Halpern, Anna B., Rodríguez-Arbolí, Eduardo, Othus, Megan, Garcia, Kelsey-Leigh A., Percival, Mary-Elizabeth M., Cassaday, Ryan D., Oehler, Vivian G., Becker, Pamela S., Appelbaum, Jacob S., Abkowitz, Janis L., Orozco, Johnnie J., Keel, Siobán B., Hendrie, Paul C., Scott, Bart L., Ghiuzeli, M. Cristina, Estey, Elihu H., Walter, Roland B.

Volltext

Description and prognostic significance of the kinetics of minimal residual disease status in adults with acute lymphoblastic leukemia treated with HyperCVAD von Cassaday, Ryan D., Stevenson, Philip A., Wood, Brent L., Becker, Pamela S., Hendrie, Paul C., Sandmaier, Brenda M., Radich, Jerald L., Shustov, Andrei R.

Volltext

Time independent factors that predict relapse in adults with acute myeloid leukemia von Lim, John J., Othus, Megan, Shaw, Carole M., Russell, Kathryn, Halpern, Anna B., Appelbaum, Jacob S., Hendrie, Paul, Walter, Roland B., Estey, Elihu H., Percival, Mary-Elizabeth M.

Volltext

Correlation between peripheral blood and bone marrow regarding FLT3-ITD and NPM1 mutational status in patients with acute myeloid leukemia von Tong, Wei-Gang, Sandhu, Vicky K, Wood, Brent L, Hendrie, Paul C, Becker, Pamela S, Pagel, John M, Walter, Roland B, Estey, Elihu H

Volltext